Intralipid 10% ( DrugBank: - )


1 disease
IDDisease name (Link within this page)Number of trials
96Crohn disease1

96. Crohn disease


Clinical trials : 2,400 Drugs : 1,391 - (DrugBank : 267) / Drug target genes : 170 - Drug target pathways : 215
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1EUCTR2013-001212-30-NL
(EUCTR)
04/07/201318/06/2013Immune modulation by parenteral Fish oil in patients with Crohn’s diseaseModulation of immune function by parenteral fish oil in patients with Crohn’s disease and high inherent Tumor Necrosis Factor-alfa production, a randomized, single blinded, cross-over study Crohn's disease;Therapeutic area: Diseases [C] - Digestive System Diseases [C06]Trade Name: Omegaven
Trade Name: Intralipid 10%
NULLAuthorised-recruitment may be ongoing or finishedFemale: yes
Male: yes
Netherlands